Concepedia

Author

Kristen Cowens

Dana-Farber Cancer Institute

Also Known As

K Cowens, Kaltman, R, Kristen B. Cowens, Kristen Cowens

33

Publications

589

Citations

7

H-Index

30

Concepts

All Affiliations

Dana-Farber Cancer InstituteModerna Therapeutics (United States)Massachusetts General HospitalHarvard UniversityUNC Lineberger Comprehensive Cancer Center
KC

About

Kristen Cowens is an author at Dana-Farber Cancer Institute specializing in medicine, radiation oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

165

2

Cell Biology

2

2

111

3

Immunology

2

2

54

4

Health Sciences

1

1

24

5

Natural Sciences

1

1

57

Kristen Cowens

×

7

Publications

580

Citations

7

H-Index

YearCitations

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

Güllü Görgün, Mehmet Samur, Kristen Cowens,

Clinical Cancer Research

2015

299

mRNA vaccine trafficking and resulting protein expression after intramuscular administration

Kimberly J. Hassett, Ivana Liric Rajlic, Kapil Bahl,

Molecular Therapy — Nucleic Acids

2023

90

Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

Ellen Weisberg, Ensar Halilovic, Vesselina G. Cooke,

Molecular Cancer Therapeutics

2015

57

Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies

Ellen Weisberg, Atsushi Nonami, Zaoping Chen,

Leukemia

2014

54

Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis

Meghan E. Free, Katherine G. Stember, Jacob J. Hess,

Journal of Autoimmunity

2019

30

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Carey K. Anders, Mark G. Woodcock, Amanda E.D. Van Swearingen,

Journal for ImmunoTherapy of Cancer

2022

26

A phase 1, open-label, multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with pembrolizumab in subjects with unresectable solid tumors (Keynote-603).

Howard A. Burris, Manish R. Patel, Daniel C. Cho,

Journal of Global Oncology

2019

24

Page 1